Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Epithelial immune activation and intracellular invasion by non-typeable Haemophilus influenzae

Brown MA. et al, (2023), Frontiers in Cellular and Infection Microbiology, 13

Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ ( FeNO ) framework

Couillard S. et al, (2022), Respirology, 27, 573 - 577

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing.

Couillard S. et al, (2022), Thorax

The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing

Kanellakis NI. et al, (2022), The Lancet Microbe, 3, e294 - e302

Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies.

Jabeen MF. et al, (2022), Microbiology spectrum

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)

Couillard S. et al, (2022), ERJ Open Research, 00570 - 2021

Azithromycin for mild-to-moderate COVID-19 - Authors' reply.

Hinks TSC. and ATOMIC2 trial authors None., (2021), The Lancet. Respiratory medicine, 9, e100 - e101

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells

Zhuang X. et al, (2021), iScience, 24, 103144 - 103144

Subcutaneous omalizumab for people with asthma

Donovan T. et al, (2021), Cochrane Database of Systematic Reviews, 2021

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial.

Hinks TSC. et al, (2021), The Lancet. Respiratory medicine

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.

Zhuang X. et al, (2021), bioRxiv

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma

Crossingham I. et al, (2021), Cochrane Database of Systematic Reviews

A randomised clinical trial of azithromycin versus standard care in ambulatory COVID-19 – the ATOMIC2 trial

Hinks TSC. et al, (2021)

Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells

Wing PAC. et al, (2021), Cell Reports, 35, 109020 - 109020

In vivo negative regulation of SARS-CoV-2 receptor, ACE2, by interferons and its genetic control

Ansari MA. et al, (2021), Wellcome Open Research, 6, 47 - 47

MAIT cell activation augments adenovirus vector vaccine immunogenicity

Provine NM. et al, (2021), Science, 371, 521 - 526

Reply to Lipworth et al.: Don’t Forget about Facilitatory Effects of Corticosteroids on β2-Adrenoceptors in Acute Asthma

Moran AM. et al, (2020), American Journal of Respiratory and Critical Care Medicine, 202, 1743 - 1744

Hypoxic and Pharmacological Activation of HIF Inhibits SARS-CoV-2 Infection of Lung Epithelial Cells

Wing PAC. et al, (2020), SSRN Electronic Journal

Boosting MAIT cells as immunotherapy: context is everything

Hinks TSC., (2020), Mucosal Immunology

ACE2, TMPRSS2 AND FURIN GENE EXPRESSION IN THE AIRWAYS OF PEOPLE WITH ASTHMA - IMPLICATIONS FOR COVID-19.

Bradding P. et al, (2020), The Journal of allergy and clinical immunology

Load More

Include forthcoming?